COVID-19

Category

Georgia State University Receives $1.3m to Study What’s Stopping Atlanta’s Black Community from Greater Participation in COVID-19 Research

Georgia State University’s School of Public Health received a two-year, $1.3 million grant from the National Institute of Health (NIH) program known as RADx Underserved Populations (RADx-UP), to help better understand the barriers and motivations for participating in...

Kentucky Healthcare Systems Gear up for Large Phase 3 ENSEMBLE Study Investigating J&J’s COVID-19 Single Dose Vaccine Candidate

Healthcare providers in Kentucky have been selected for a major global Phase 3 COVID-19 vaccine clinical trial, including University of Kentucky (UK) Hospital, Baptist Health Lexington and Norton Healthcare in Louisville serve as trial site locations for the massive...

The COVAS Tool: Kaiser Permanente Southern California Develops Tool to Predict Outcomes for COVID-19 in Emergency Dept. Setting

Kaiser Permanente Southern California Department of Research & Evaluation has developed a COVID-19 risk assessment factoring in a number of patient variables enabling a critical poor outcome without the need for any laboratory or diagnostic testing as reported in...

Novartis Pays $50m Upfront Cash for License and Stock in Mesoblast to Access Mesenchymal Stromal Cells Regenerative Therapy Platform

Novartis recently inked an exclusive worldwide license and collaboration agreement with regenerative therapy venture Mesoblast to develop, commercialize and manufacture remestemcel-L for the treatment of acute respiratory distress syndrome (ARDS), including that...

Pin It on Pinterest